These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35325550)

  • 21. SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination.
    Baird JK; Jensen SM; Urba WJ; Fox BA; Baird JR
    J Hum Lact; 2021 Aug; 37(3):492-498. PubMed ID: 34297643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of Anti-SARS-CoV-2 Neutralizing Antibodies in Breast Milk: Impact of Maternal COVID-19 Vaccination and Infection.
    Suteerojntrakool O; Mekangkul E; Maitreechit D; Khabuan S; Sodsai P; Hirankarn N; Thumbovorn R; Chomtho S
    Breastfeed Med; 2024 May; 19(5):340-348. PubMed ID: 38506333
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after
    Calvo-Lerma J; Bueno-Llamoga P; Bäuerl C; Cortés-Macias E; Selma-Royo M; Pérez-Cano F; Lerin C; Martínez-Costa C; Collado MC
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants.
    Longueira Y; Ojeda DS; Battistelli RBA; Sanchez L; Oviedo Rouco S; Albano D; Guevara E; Valls V; Pando MA; Gamarnik AV
    Front Immunol; 2022; 13():909995. PubMed ID: 36263055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Persistence of Specific Immunoglobulin A Against SARS-CoV-2 in Human Milk After Maternal COVID-19 Vaccination.
    Suteerojntrakool O; Mekangkul E; Ananta P; Maitreechit D; Khabuan S; Sodsai P; Hirankarn N; Thumbovorn R; Chomtho S
    Breastfeed Med; 2023 Dec; 18(12):943-950. PubMed ID: 38100444
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review.
    Nicolaidou V; Georgiou R; Christofidou M; Felekkis K; Pieri M; Papaneophytou C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of COVID-19 Vaccination on Lactating Women: A Systematic Review of the Literature.
    Muyldermans J; De Weerdt L; De Brabandere L; Maertens K; Tommelein E
    Front Immunol; 2022; 13():852928. PubMed ID: 35464406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination-Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review.
    Dimitroglou M; Sokou R; Iacovidou N; Pouliakis A; Kafalidis G; Boutsikou T; Iliodromiti Z
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2-specific antibodies and neutralization capacity in breast milk following infection vs vaccination.
    Leung HYH; Leung BW; Gil MM; Rolle V; Moungmaithong S; Wang CC; Poon LC
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):425-427. PubMed ID: 35653222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
    Rick AM; Lentscher A; Xu L; Wilkins MS; Nasser A; Tuttle DJ; Megli C; Marques ETA; McElroy AK; Williams JV; Martin JM
    PLoS One; 2023; 18(6):e0287103. PubMed ID: 37310982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Milk SARS-CoV-2 Antibodies up to 6 Months After Vaccination.
    Perez SE; Luna Centeno LD; Cheng WA; Marentes Ruiz CJ; Lee Y; Congrave-Wilson Z; Powell RL; Stellwagen L; Pannaraj PS
    Pediatrics; 2022 Feb; 149(2):. PubMed ID: 34981122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges of breastfeeding during COVID-19 and baby friendly protocols adopted at a maternity health center in the northern Emirates of UAE: a comprehensive review.
    Ahmad H; Qureshi GS; Odeh LB; Annamma LM; Hossain A; Khan A; Haque S; Rasheed AK
    J Health Popul Nutr; 2024 May; 43(1):65. PubMed ID: 38745335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion.
    Pieri M; Maniori MA; Shahabian L; Kanaan E; Paphiti-Demetriou I; Pipis S; Felekkis K; Nicolaidou V; Papaneophytou C
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study.
    Charepe N; Gonçalves J; Juliano AM; Lopes DG; Canhão H; Soares H; Serrano EF
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):632. PubMed ID: 34535094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies Against SARS-CoV-2 in Human Milk: Milk Conversion Rates in the Netherlands.
    Juncker HG; Romijn M; Loth VN; Ruhé EJM; Bakker S; Kleinendorst S; de Groot CJM; Pajkrt D; Korosi A; van Goudoever JB; van Gils MJ; van Keulen BJ
    J Hum Lact; 2021 Aug; 37(3):469-476. PubMed ID: 33982613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the SARS-CoV-2-specific antibody response in human milk after homologous and heterologous booster vaccinations.
    Mulleners SJ; Juncker HG; Ruhé EJM; Korosi A; van Goudoever JB; van Gils MJ; van Keulen BJ
    Commun Biol; 2023 Jan; 6(1):100. PubMed ID: 36697496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of maternal COVID-19 vaccination in providing immunological protection to the newborn.
    Jorgensen SCJ; Burry L; Tabbara N
    Pharmacotherapy; 2022 Jan; 42(1):58-70. PubMed ID: 34816467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies.
    Pace RM; Williams JE; Järvinen KM; Meehan CL; Martin MA; Ley SH; Barbosa-Leiker C; Andres A; Yeruva L; Belfort MB; Caffé B; Navarrete AD; Lackey KA; Pace CDW; Gogel AC; Fehrenkamp BD; Klein M; Young BE; Rosen-Carole C; Diaz N; Gaw SL; Flaherman V; McGuire MA; McGuire MK; Seppo AE
    Front Immunol; 2021; 12():801797. PubMed ID: 35003130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women.
    Demers-Mathieu V; Hakansson AP; Hall S; Lavangnananda S; Fels S; Medo E
    Breastfeed Med; 2022 Feb; 17(2):163-172. PubMed ID: 34809492
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.